Literature DB >> 8286846

Transcription from TATA-less promoters: dihydrofolate reductase as a model.

J C Azizkhan1, D E Jensen, A J Pierce, M Wade.   

Abstract

The promoters of many of the genes encoding the so-called "housekeeping" enzymes, oncogenes, growth factors and their receptors, and transcription factors, do not contain a canonical TATA box, which is known to direct transcription initiation. The mechanisms through which TATA-less promoters are regulated, and their transcription start sites selected, have begun to yield to investigation. Using the dihydrofolate reductase (DHFR) gene as a model, recent work on this group of genes has been reviewed. Control of transcription initiation and the role of "initiator" sequences, as well as their binding factors, in particular YY1 and E2F, are addressed. In the DHFR gene, neither the E2F site at the major initiation region nor the upstream Sp1 sites can alone produce wild-type initiation, despite the fact that each of these sites has certain properties of initiators. Many TATA-less genes are growth regulated, that is, transcription is increased in response to stimulation of cell proliferation. Although both Sp1 and E2F have been implicated in growth regulation, our recent studies suggest that Sp1 sites alone can confer a growth-dependent increase in transcription in the late G1 and early S phases of the cell cycle. The regulatory role of E2F, which binds to many TATA-less promoters and mediates viral stimulation of transcription, is also reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286846

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  76 in total

1.  The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Differential expression of potato U1A spliceosomal protein genes: a rapid method for expression profiling of multigene families.

Authors:  A F Ibrahim; J A Watters; J W Brown
Journal:  Plant Mol Biol       Date:  2001-03       Impact factor: 4.076

3.  Genomic organization, chromosomal mapping and promoter analysis of the mouse selenocysteine tRNA gene transcription-activating factor (mStaf) gene.

Authors:  K Adachi; M Katsuyama; S Song; T Oka
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

4.  Bayesian variable selection for gene expression modeling with regulatory motif binding sites in neuroinflammatory events.

Authors:  Kuang-Yu Liu; Xiaobo Zhou; Kinhong Kan; Stephen T C Wong
Journal:  Neuroinformatics       Date:  2006

5.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.

Authors:  S Y Lin; A R Black; D Kostic; S Pajovic; C N Hoover; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide.

Authors:  Xianqiong Zou; Yongguang Gao; Vivian R Ruvolo; Tawnya L Gardner; Peter P Ruvolo; Rhoderick E Brown
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

7.  Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene.

Authors:  T Wu; T Ikezono; C W Angus; J H Shelhamer
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Differential effects of shear stress and cyclic strain on Sp1 phosphorylation by protein kinase Czeta modulates membrane type 1-matrix metalloproteinase in endothelial cells.

Authors:  Ji Il Kim; Alfredo C Cordova; Yo Hirayama; Joseph A Madri; Bauer E Sumpio
Journal:  Endothelium       Date:  2008 Jan-Feb

9.  Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.

Authors:  L Zhang; S C Wong; L H Matherly
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels.

Authors:  E M Glare; M Divjak; M J Bailey; E H Walters
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.